Frequently Asked Questions about Compugen Ltd. (CGEN)

Name: Compugen Ltd. (CGEN) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Compugen Ltd. (CGEN) do?

Accepted Answer

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I cl...

Question 2

Is Compugen Ltd. (CGEN) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of CGEN reveals an Altman Z-Score of 0.68 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($0.07B most recent), help investors decide if CGEN fits their risk profile.

Question 3

What is the current P/E ratio for CGEN?

Accepted Answer

As of the latest trading session, Compugen Ltd. (CGEN) has a trailing P/E ratio of 6.87.

Question 4

Who is the CEO of Compugen Ltd.?

Accepted Answer

The current Chief Executive Officer of Compugen Ltd. is Eran Ophir.

Question 5

What was CGEN's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Compugen Ltd. reported annual revenues of $0.07B (2025), $0.03B (2024), $0.03B (2023), $0.01B (2022), $0.01B (2021) respectively.

Question 6

Does CGEN pay a dividend?

Accepted Answer

Compugen Ltd. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does CGEN have?

Accepted Answer

In its latest reporting period, Compugen Ltd. generated $0.03B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Compugen Ltd.?

Accepted Answer

The Price-to-Book (P/B) ratio for Compugen Ltd. (CGEN) is currently 2.36.

Question 9

What is the Price-to-Sales (P/S) ratio of CGEN?

Accepted Answer

Based on trailing twelve-month data, Compugen Ltd. (CGEN) trades at a Price-to-Sales (P/S) ratio of 3.35.

Question 10

What is Compugen Ltd.'s Return on Equity (ROE)?

Accepted Answer

Compugen Ltd. (CGEN) has a Return on Equity (ROE) of 55.68%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	31.6M	0	-306K	31.3M	31.3M
2024-12	49.6M	3M	-118K	49.5M	46.5M
2023-12	-35.9M	3.6M	-172K	-36.1M	-39.6M
2022-12	-33.9M	4.3M	-487K	-35M	-38.7M
2021-12	-23.2M	4.3M	-292K	-23M	-27.8M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	31.6M	0	-306K	31.3M	31.3M
2024-12	49.6M	3M	-118K	49.5M	46.5M
2023-12	-35.9M	3.6M	-172K	-36.1M	-39.6M
2022-12	-33.9M	4.3M	-487K	-35M	-38.7M
2021-12	-23.2M	4.3M	-292K	-23M	-27.8M